@dansfera: Ever wonder why your biotech investments seem to shrink even when the company keeps hitting milestones? It’s often the hidden trap of the cash runway. When biopharma companies run dry, they have to raise more capital—but in a high-interest-rate environment, the math changes. Investors demand steeper discounts, meaning the exact same investment now buys a much larger slice of the pie, leaving original shareholders heavily diluted. It’s a harsh reality of the industry that can wipe out potential gains. #biotech #investing #biopharma #stockmarket #finance

dansfera

Open In TikTok:

Region: US

Saturday 19 September 2026 06:28:23 GMT